Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Safe and effective tumour necrosis factor-α inhibitor (etanercept) treatment of chronic episodic arthritis in a patient with cystic fibrosis

Research output: Contribution to journalLetterResearchpeer-review

View graph of relations
Original languageEnglish
JournalScandinavian Journal of Rheumatology
Volume45
Issue number4
Pages (from-to)330-1
Number of pages2
ISSN0300-9742
DOIs
Publication statusPublished - Jul 2016

    Research areas

  • Antirheumatic Agents, Arthritis, Chronic Disease, Cystic Fibrosis, Etanercept, Humans, Male, Middle Aged, Case Reports, Letter

ID: 49821292